Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wild, James
PROSPER-FM, NCT05243511: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management	Completed	3	275	US	Digital ACT, Digital Symptom Tracker	Swing Therapeutics, Inc.	Fibromyalgia	05/23	05/23
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection	Completed	2	63	US	TNX-102 SL, Placebo SL Tablet	Tonix Pharmaceuticals, Inc.	Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID	07/23	07/23
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Completed	2	797	NA	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	08/24
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain	Terminated	2	314	Europe, Canada, Japan, US, RoW	GSK3858279, Placebo	GlaxoSmithKline	Pain, Osteoarthritis, Knee	08/24	12/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wild, James
PROSPER-FM, NCT05243511: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management	Completed	3	275	US	Digital ACT, Digital Symptom Tracker	Swing Therapeutics, Inc.	Fibromyalgia	05/23	05/23
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection	Completed	2	63	US	TNX-102 SL, Placebo SL Tablet	Tonix Pharmaceuticals, Inc.	Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID	07/23	07/23
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Completed	2	797	NA	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	08/24
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain	Terminated	2	314	Europe, Canada, Japan, US, RoW	GSK3858279, Placebo	GlaxoSmithKline	Pain, Osteoarthritis, Knee	08/24	12/24